name:-0.027369022369385
name:-0.031072854995728
name:-0.00048685073852539
Millan; Mark Patent Filings

Millan; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Millan; Mark.The latest application filed is for "use of agomelatine in obtaining medicaments intended for the treatment of obsessive-compulsive disorder (ocd)".

Company Profile
0.25.22
  • Millan; Mark - Le Pecq FR
  • Millan; Mark - Paris FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Use Of Agomelatine In Obtaining Medicaments Intended For The Treatment Of Obsessive-compulsive Disorder (ocd)
App 20120309838 - Laigle; Laurence ;   et al.
2012-12-06
Chromene compounds, a process for their preparation and pharmaceutical compositions containing them
Grant 8,247,441 - De Nanteuil , et al. August 21, 2
2012-08-21
Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
Grant 7,960,438 - Delalleau , et al. June 14, 2
2011-06-14
Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
Grant 7,947,852 - Yous , et al. May 24, 2
2011-05-24
Chromene compounds, a process for their preparationand pharmaceutical compositions containing them
App 20110021490 - De Nanteuil; Guillaume ;   et al.
2011-01-27
Naphthalene Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them
App 20100168244 - Yous; Said ;   et al.
2010-07-01
Naphthalene Compounds, A Process For Their Preparation And Pharmaceutical Compositions Containing Them
App 20100137446 - Yous; Said ;   et al.
2010-06-03
Piperazine compounds
Grant 7,612,061 - Peglion , et al. November 3, 2
2009-11-03
Piperazine compounds
App 20090076030 - Peglion; Jean-Louis ;   et al.
2009-03-19
Piperazine compounds
App 20090075982 - Peglion; Jean-Louis ;   et al.
2009-03-19
Tetracyclic compounds
Grant 7,470,683 - Peglion , et al. December 30, 2
2008-12-30
Piperazine compounds
Grant 7,465,733 - Peglion , et al. December 16, 2
2008-12-16
Naphthalene compounds
Grant 7,462,741 - Yous , et al. December 9, 2
2008-12-09
Indanyl-piperazine compounds
Grant 7,442,692 - De Nanteuil , et al. October 28, 2
2008-10-28
Naphthalene compounds
Grant 7,435,850 - Yous , et al. October 14, 2
2008-10-14
Tetracyclic compounds
App 20080076765 - Peglion; Jean-Louis ;   et al.
2008-03-27
Naphthalene compounds
App 20080004350 - Yous; Said ;   et al.
2008-01-03
Naphthalene compounds
App 20080004349 - Yous; Said ;   et al.
2008-01-03
Use of agomelatine in obtaining medicaments intended for the treatment of Generalized Anxiety Disorder
App 20070238792 - Delalleau; Bruno ;   et al.
2007-10-11
Piperazine compounds
App 20060229318 - Peglion; Jean-Louis ;   et al.
2006-10-12
Indanyl-piperazine compounds
App 20060223830 - De Nanteuil; Guillaume ;   et al.
2006-10-05
Indoline compounds
Grant 7,053,108 - Lavielle , et al. May 30, 2
2006-05-30
Diphenylurea compounds
Grant 7,026,357 - Lavielle , et al. April 11, 2
2006-04-11
Benzoindoline compounds
Grant 6,998,403 - Lavielle , et al. February 14, 2
2006-02-14
Benzoindoline compounds
App 20050059675 - Lavielle, Gilbert ;   et al.
2005-03-17
Diphenylurea compounds
App 20040224993 - Lavielle, Gilbert ;   et al.
2004-11-11
New indoline compounds
App 20040192736 - Lavielle, Gilbert ;   et al.
2004-09-30
Diphenylurea compounds
Grant 6,784,183 - Lavielle , et al. August 31, 2
2004-08-31
Indoline compounds, a process for their preparation and pharmaceutical compositions containing them
Grant 6,759,421 - Lavielle , et al. July 6, 2
2004-07-06
Pyrimidin-4-one compounds
Grant 6,747,032 - Lavielle , et al. June 8, 2
2004-06-08
Cyclobutaindolecarboxamide compounds
Grant 6,743,818 - Peglion , et al. June 1, 2
2004-06-01
Indoline compounds and to pharmaceutical compositions containing them
App 20030199555 - Lavielle, Gilbert ;   et al.
2003-10-23
Pyrimidin-4-one compounds
App 20030087916 - Lavielle, Gilbert ;   et al.
2003-05-08
Cyclobutaindolecarboxamide compounds
App 20030032812 - Peglion, Jean-Louis ;   et al.
2003-02-13
Piperidine compounds
App 20020161228 - Peglion, Jean Louis ;   et al.
2002-10-31
Diphenylurea compounds
App 20020025965 - Lavielle, Gilbert ;   et al.
2002-02-28
Beta-carboline compounds
Grant 6,350,757 - Goldstein , et al. February 26, 2
2002-02-26
Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds
App 20020019380 - Peglion, Jean-Louis ;   et al.
2002-02-14
Cyclobutaindolecarboxamide compounds
App 20010044426 - Peglion, Jean-Louis ;   et al.
2001-11-22
Cyano-indole serotonin-reuptake inhibitor compounds
Grant 6,239,129 - Lavielle , et al. May 29, 2
2001-05-29
Substituted hydrochromenopyrroles
Grant 6,090,837 - Lavielle , et al. July 18, 2
2000-07-18
Indanol compounds
Grant 5,958,927 - Peglion , et al. September 28, 1
1999-09-28
3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds
Grant 5,780,474 - Peglion , et al. July 14, 1
1998-07-14
Indole, indazole and benzisoxazole compounds
Grant 5,703,070 - Lavielle , et al. December 30, 1
1997-12-30
New benzodioxane compounds
Grant 5,500,443 - Lavielle , et al. March 19, 1
1996-03-19
N-substituted N'-heterobicyclic piperazines having pharmaceutical activity
Grant 5,464,834 - Peglion , et al. November 7, 1
1995-11-07
1,4-disubstituted piperazines
Grant 5,194,437 - Peglion , et al. March 16, 1
1993-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed